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Abstract We investigated the effect of sub-chronic soy-
bean oil (SO) treatment on the insulin secretion and fatty
acid composition of islets of Langerhans obtained from
Goto-Kakizaki (GK), a model of type 2 diabetes, and nor-
mal Wistar rats. We observed that soybean-treated Wistar
rats present insulin resistance and defective islet insulin
secretion when compared with untreated Wistar rats. The
decrease in insulin secretion occurred at all concentra-
tions of glucose and arginine tested. Furthermore we
observed that soybean-treated normal islets present a sig-
nificant decrease in two saturated fatty acids, myristic
and heneicosanoic acids, and one monounsaturated
eicosenoic acid, and the appearance of the monounsatu-
rated erucic acid. Concerning diabetic animals, we
observed that soybean-treated diabetic rats, when com-
pared with untreated GK rats, present an increase in plas-
ma non-fasting free fatty acids, an exacerbation of islet
insulin secretion impairment in all conditions tested and
a significant decrease in the monounsaturated palmitole-
ic acid. Altogether our results show that SO treatment
results in a decrease of insulin secretion and alterations
on fatty acid composition in normal and diabetic islets.
Furthermore, the impairment of insulin secretion, islet
erucic acid and fasting plasma insulin levels are similar
in treated normal and untreated diabetic rats, suggesting
that SO could have a deleterious effect on β-cell function
and insulin sensitivity.
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Introduction
Type 2 diabetes is one of the most common metabolic dis-
eases. Chronic hyperglycaemia is a consequence of the
interplay between β-cell dysfunction, insulin resistance
and elevated hepatic glucose production [1]. Changes in
dietetic habits and the increase in sedentary life are the
main causes of the rise of the prevalence of type 2 dia-
betes [1, 2].
The similarity between fatty acids’ effects on the
insulin secretory response of isolated islets and the mech-
anisms underlying type 2 diabetes has been described [3,
4]. The influence of free fatty acid (FFA) on insulin secre-
tion is associated with the suppression of peripheral glu-
cose uptake, stimulation of hepatic gluconeogenesis,
defect in islet glucose recognition and fatty acid oxida-
tion, as stated in the fuel concept and the Randle cycle
hypothesis, the latter also known as the glucose–fatty acid
cycle [5–10]. More recently, the action of fatty acids on
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insulin secretion has been related to a mechanism involv-
ing modulation of uncoupling protein-2 (UCP-2) expres-
sion [11]. In cells, fatty acids are mainly localised in
membrane phospholipids and are a major component of
intracellular diacylglycerol, phosphatidic acid and triacyl-
glycerol [12, 13]. Thus, it is clear that changes in the con-
tents of fatty acids can influence membrane structure and
function of islet cells, namely the activities of β-cell chan-
nels and receptors such as K+, Ca2+ and voltage-sensitive
channels, glucose transporters, and adenylate cyclase-
coupled and phospholipase C-coupled receptors [14].
Furthermore, phospholipids, diacylglycerol, phosphatidic
acid and triacylglycerol are implicated in different cellu-
lar mechanisms, as they can be precursors or generators of
important molecules such as prostaglandins and
ceramides and they are involved also in gene expression,
influencing a range of glucose and lipid signalling path-
ways [8, 10, 13–17].
Accumulating evidence suggests that chain length, spa-
tial conformation and degree of saturation of FFAs pro-
foundly influence the insulinotropic potency and the stim-
ulation of KATP channel activity [7, 16, 18–20]. Studies
focussed on fatty acids chain length reported that the
increase of the number of carbons has a negative effect on
insulin release by increasing β-cell KATP channel activity
and induces uncoupling of β-cell oxidative phosphoryla-
tion [7, 16, 18]. Concerning the spatial conformation, trans
fatty acids induce better results in insulin release than the
corresponding cis isoforms [21]. However, it has been
shown that cis monounsaturated fatty acids (MUFAs) have
a positive effect on glycaemic control [16, 22].
Recently, it has been reported that diets based on
polyunsaturated fatty acids have a higher protective effect
in diabetic patients at cardiovascular risk when compared
with those based on MUFAs or saturated fatty acids [22].
Previous studies suggested that a MUFA-enriched diet
may be useful in the treatment of patients with glucose
intolerance or type 2 diabetes [23]. However, studies
showing a positive association between saturated fatty
acids and a higher risk of type 2 diabetes are more consis-
tent [18, 20, 24]. It has been shown that palmitic acid
(C16:0) is toxic to β-cells, even at moderate levels [19,
25]. This fatty acid affects glucose-induced insulin gene
expression, ceramide synthesis and activates mitochon-
drial apoptotic pathways [13, 15, 26–28]. In contrast, the
monounsaturated palmitoleic acid (C16:1) promotes β-
cell proliferation at low glucose concentrations, improves
β-cell function and counteracts the negative effects of
palmitic acid [27]. Along the same line, it has been shown
that the saturated stearic acid (C18:0) has proapoptotic
properties unlike equivalent concentrations of the polyun-
saturated linoleic acid (C18:2n6c) [15, 29]. Concerning
the monounsaturated oleic acid (C18:1n9c), contradictory
results about its proapoptotic properties have been
obtained [15, 30].
There is controversial evidence concerning the effects
of soybean (oil, diet, protein) treatment. Lipids based on
soybean oil (SO) are traditionally used as nutritional sup-
port for surgical or critical patients [31, 32]. Some studies
with normal rats on a SO diet reported an increase in body
weight and fat gain as well as an impairment of glucose
tolerance [33] and insulin resistance [34, 35]. However, a
rise of glucose-stimulated insulin secretion (GSIS) was
also observed [36]. Dietary soybean has positive effects
on lipid and glucose levels and cardiovascular risk mark-
ers [37]. Furthermore, SO is a vegetal oil rich in antioxi-
dants. This property has been explored and discussed in
studies of oxidative stress [35].
Previous studies performed on Goto-Kakizaki (GK)
rats, a spontaneously type 2 diabetic animal model, on a
high-fat diet, demonstrated impaired GSIS [11] or an
enhancement of insulin secretion during oral glucose tol-
erance test [38]. It has been shown that in Wistar (W) nor-
mal rats, high-fat feeding has no effect on islet insulin
secretion, insulin content and insulin mRNA level [11],
but induces insulin resistance [38].
This study was designed to examine and clarify the
effects of sub-chronic (7 days) SO treatment on insulin
secretion and fatty acid composition of islets of
Langerhans obtained from diabetic GK and normal W rats.
Research design and methods
Materials
Liberase was supplied by Roche Diagnostic GmbH, Mannheim,
Germany. Guinea pig-rat insulin serum was obtained from
Biotrend Chemikalien, GmbH, Germany and rat insulin standard
from Linco Research Inc, USA. All the other chemicals were
supplied by Sigma Chemicals Co., USA or Merck Darmstad,
Germany and were of the highest grade of purity commercially
available.
Animals
Female spontaneously diabetic GK rats (aged 12 weeks) were
obtained from our local breeding colony (Laboratory Research
Center, University Hospital, Coimbra, Portugal). Non-diabetic
female Wistar rats, of similar age, were also obtained from our
local colony. They were kept under controlled light (12 h/12 h
day/night cycle), temperature (22–24°C) and humidity (50–60%)
conditions and had free access to water and powdered rodent
chow (diet AO4-Panlab, Spain). W and GK rats were divided in
two groups [untreated (W, GK) and a soybean oil treated (Ws,
GKs) for 7 days (2 ml/kg/day, i.p.)]. Experiments were conduct-
ed 24 h after the last injection. Adhering to procedures approved
by the Institutional Animal Care and Use Committee, the animals
were sacrificed by cervical displacement.
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Body weight and blood glucose determination
Body weight was measured before sacrifice, in fed animals.
Blood glucose levels were determined through the glucose-
oxidase reaction using a glucometer and compatible reactive
tests (glucometer-Elite-Bayer, Portugal) after an overnight fast
and 2 h after intraperitoneal glucose load (1.8 g/kg body
weight).
Plasma insulin and free fatty acid determinations
Blood samples (1 ml) were taken by cardiac puncture from
anaesthetised animals (non-fasting and overnight fasting)
with ketamine chloride (75 mg/kg, i.m.; Parke Davis, Ann
Arbor, MI, USA) and chlorpromazine chloride (2.65 mg/kg,
i.m., Laboratórios Victoria, Portugal). Plasma was immediate-
ly stored at -20°C for the measurement of plasma insulin
and FFAs.
Plasma insulin levels were determinated by competitive
enzyme-linked immunosorbent assay (ELISA; see ‘Insulin
assay’ section) and FFA levels by Half-Micro test (Roche
Applied Science, Penzberg, Germany).
Insulin sensitivity
Insulin sensitivity was measured through two different indexes:
homeostasis model assessment (HOMA) calculated as
(G0)x(I0)/22.5, where G0 is fasting glucose (mmol/l) and I0 is
fasting insulin (μU/ml) and quantitative insulin-sensitivity
check index (QUICKI), calculated as 1/[log(G0)+log(I0)],
where G0 is fasting glucose (mg/dl) and I0 is fasting insulin
(μU/ml) [39].
Islet isolation
Rat pancreatic islets were isolated from fed animals by liberase
digestion, as previously described [40]. For fatty acid analysis,
isolated islets (n=200/aliquot) were stored at -20°C.
Islet insulin release samples preparation
Isolated islets were pre-incubated for 60 min in Krebs medi-
um supplemented with 8 mM glucose and 30 mg/ml bovine
serum albumin (BSA) protease free. The medium was
replaced with Krebs solution (in mM: 120 NaCl; 5 KCl;
25 NaHCO3; 1.13 MgCl2·6H2O; 2.56 CaCl2·2H2O; gassed
with 95% O2–5% CO2; pH 7.4) containing 2 mM glucose
and 1 mg/ml BSA, for 30 min. Then, insulin released from
isolated islets was measured under static incubation condi-
tions using 5 islets/well plated on a 12-well cluster incubated
with a particular secretagogue [2 ml Krebs solution contain-
ing glucose (2, 8 or 11 mM) or arginine (20 mM) plus gluco-
se (11 mM) and 1 mg/ml BSA]. After 30 min, samples
were collected and stored at -20°C for subsequent insulin
measurement.
Insulin assay
The levels of plasma insulin and insulin released from islets were
measured by competitive ELISA with the insulin-capturing anti-
body immobilised directly in the solid phase as previously
described [40, 41]. Immunoglobulin G-certified microtitre plates
(96 wells, Nunc, Roskilde, Denmark) were incubated overnight at
4°C, with guinea pig-rat insulin serum and rat insulin used as stan-
dard. Plasma and islet insulin samples were diluted in PBS and
Hepes buffers, respectively, and supplemented with BSA. Each
condition was run in duplicate. 3,3',5,5'-Tetramethylbenzidine
(TMB) liquid substrate system (Sigma Chemicals Co., USA) was
used as substrate for the insulin-peroxidase conjugate and the
reaction product was assayed spectrophotometrically at 450 nm
(Microplate reader – Model 550, Bio-Rad), after a 30-min incuba-
tion period with TMB at room temperature (the reaction was
stopped with sulphuric acid).
Insulin released from islets was expressed as fmol/5 islets/30
min and plasma insulin levels as pmol/l.
Islet fatty acid analysis
Fatty acid composition was analysed in isolated islets obtained
from untreated and treated W and GK rats. Fatty acid composi-
tion in SO was also measured.
We prepared fatty acid methyl esters (FAMEs) according to
a procedure previously described [42], with slight modifications
[43]. Briefly, lipids were extracted from Langerhans islet with
methanol/chloroform (1:2). The mixture was centrifugated at
4°C. The upper layer was removed by aspiration and the inter-
phase by filtration. The filtrate was evaporated to dryness under
a N2 flow and the residue was redissolved in chloroform. N2
was blown over the samples to avoid fatty acid oxidation. The
FAME was prepared using 5% HCl in methanol that was used
as a derivatising reagent, at 60°C for 3 h. FAMEs were analysed
with a Perkin–Elmer gas chromatograph adapted for capillary
columns with helium as the carrier gas. The linear velocity was
35 cm/s with a flow rate of 4.0 ml/min. We used an Alltech cap-
illary column (AT-SILAR 30 mx0.53 mm IDx0.5 μ) with a tem-
perature programme as follows: 5 min at 140°C; 4°C/min to
210°C; 10 min at the upper temperature. The results were cal-
culated using appropriate integration software (JCL 6000 chro-
matography data system).
Unsaturation index (UI) was calculated according to the for-
mula, UI=Σ% of unsaturated fatty acidsxnumber of double bonds
of each unsaturated fatty acid [43].
Statistical analysis
Data were expressed as means±SEM of the indicated number of
experiments. Statistical significance was tested using unpaired
Student’s t-test; p<0.05 was considered statistically significant.
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Results
Body weight, blood glucose and plasma insulin levels
As shown in Table 1, body weight of diabetic rats is sig-
nificantly lower, while blood glucose levels 2 h after glu-
cose load are significantly higher when compared with
normal animals. With SO treatment, normal and diabetic
rats did not present significant alterations in body weight
and blood glucose levels 2 h after glucose load (Table 1)
when compared with normal and diabetic untreated rats,
respectively.
It was also observed that fasting plasma insulin
(113.6%), blood glucose (72.2%) levels and HOMA index
(120.0%) are significantly higher and QUICKI (18.2%)
significantly lower in untreated GK rats when compared
with untreated W rats (Fig. 1). In normal rats, SO treat-
ment did not change fasting blood glucose levels but sig-
nificantly increased fasting insulinaemia (146%; Fig. 1b)
and altered HOMA and QUICKIs (Fig. 1c and d). In dia-
betic rats, SO significantly decreased fasting blood glu-
cose levels (34%; Fig. 1a). In these animals, fasting plas-
ma insulin levels and HOMA and QUICKIs did not pres-
ent any statistical difference (Fig. 1b, c and d).
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Table 1 Body weight, glucose levels measured 2 h after glucose load and non-fasting and fasting plasma FFAs in treated and untreated
non-diabetic and diabetic rats
Non-diabetic rats Diabetic rats
W Ws GK GKs
Body weight (g) 247±5.2 267±4.8 203±4.5*** 194±3.7§
Glucose level 2 h after glucose load (mmol/l) 87±4.3 90±3.8 318.4±16.9*** 295±16.8§
Non-fasting plasma FFA (mM) 0.28±0.08 0.21±0.07 0.21±0.05*** 0.42±0.06§
Fasting plasma FFA (mM) 0.84±0.04 0.64±0.1 0.71±0.1*** 0.61±0.1§
W, untreated Wistar rats; Ws, SO-treated Wistar rats; GK, untreated Goto-Kakizaki rats; GKs, SO-treated Goto-Kakizaki rats. The values
shown represent the means±SEM of n=8–20 animals in each group. ***p<0.005, vs. untreated Wistar. §p<0.05, vs. untreated GK
Fig. 1 Fasting blood glucose
(a), fasting plasma insulin (b),
HOMA index (c) and QUICKI
(d) in non-diabetic and diabet-
ic rats. W, untreated Wistar
rats; Ws, SO-treated Wistar
rats; GK, untreated Goto
Kakizaki rats; GKs, SO-treat-
ed Goto Kakizaki rats. The
values shown represent the
means±SEM of n=8–17 ani-
mals in each group. *p<0.05;
**p<0.01; ***p<0.005, vs.
untreated Wistar. §§§p<0.005,
vs. untreated GK
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Plasma free fatty acids levels 
Diabetes per se and SO treatment in normal rats did not
induce a significant alteration in plasma fasting and non-
fasting FFAs levels (Table 1). However, in diabetic rats,
SO treatment significantly increased (100%) non-fasting
FFA levels (Table 1).
Islet insulin secretion
Isolated islets from untreated diabetic rats were not
responsive to glucose. Under static incubation conditions
we observed an impairment of GSIS (G2, 46%; G8,
74.1%; G11, 81.1%), when compared with untreated nor-
mal islets (Fig. 2a). SO treatment induced an impairment
of isolated islet insulin secretion from normal rats (G2,
64%; G8, 70%; G11, 76%; G11+arg, 57%; Fig. 2b) and
worsened insulin response of diabetic islets (G2, 69%;
G8, 68%; G11, 65%; G11+arg 20, 75%; Fig. 2c).
Islet insulin response from SO-treated W rats was sim-
ilar to that of untreated GK rats (Fig. 2d).
Fatty acid composition of isolated islets
When we compared islet fatty acid composition in both
untreated groups of animals (Fig. 3a), we observed that
diabetic animals present a decrease in myristic acid
(C14:0) (47.8%) and an increase in palmitoleic acid
(C16:1) (114.3%) levels. Furthermore, the presence of the
monounsaturated erucic acid (C22:1) is observed in dia-
betic islets (Fig. 3a).
Treated normal rats presented a significant decrease
(Fig. 3b) in two saturated fatty acids, myristic (C14:0)
(34%) and heneicosanoic (C21:0) (72%) acids and one
MUFA, eicosenoic acid (C20:1) (68%). Furthermore, SO
treatment induced the appearance of the monounsaturated
erucic acid (C22:1) (Fig. 3b and d). In diabetic rats, SO
treatment induced a significant decrease in the monoun-
saturated palmitoleic acid (C16:1) (53%; Fig. 3c).
However, SO did not induce a significant alteration in the
saturation/unsaturation ratio, unsaturation index and in
the percentage of saturated, polyunsaturated, monounsat-
urated and total unsaturated fatty acids when islets isolat-
ed from the four different groups of animals were com-
pared (Table 2).
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Fig. 2 The effects of glucose-induced and glucose plus arginine-induced insulin secretion from non-diabetic and diabetic islets isolated
from untreated and treated animals. a Comparison between untreated Wistar and GK rats. b Comparison between untreated and treated
Wistar rats. c Comparison between untreated and treated GK rats. d Comparison between treated Wistar and untreated GK rats. W, untreat-
ed Wistar rats; Ws, SO-treated Wistar rats; GK, untreated Goto Kakizaki rats; GKs, SO-treated Goto Kakizaki rats. G2, 2 mM glucose; G8,
8 mM glucose; G11, 11 mM glucose; G11+arg20, 11 mM glucose+20 mM arginine. The values shown represent the means±SEM of
n=17–28 experiments in each group. ***p<0.005, vs. untreated Wistar. §§p<0.01, vs. untreated GK
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Discussion
The GK rat is a spontaneously non-obese diabetic animal
model, produced by selective inbreeding of Wistar rats
presenting the highest glucose levels during the oral glu-
cose tolerance test [44]. This animal model is charac-
terised by β-cell mass reduction, β-cell dysfunction and
insulin resistance leading to diabetes mellitus [40, 45, 46].
We observed that diabetic GK rats have lower body
weight, increased fasting insulinaemia, higher levels of
glucose, fasting and 2 h after glucose load, and insulin
resistance (Table 1, Fig. 1), when compared with normal
W rats. These results are in agreement with previous stud-
ies [40, 45, 46]. However, there is no significant differ-
ence in non-fasting and fasting FFA levels between nor-
mal and diabetic rats (Table 1), suggesting that the cycle
Randle hypothesis is not involved in the diabetic syn-
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Fig. 3 Fatty acid composition of non-diabetic and diabetic islets isolated from untreated and treated animals. a Comparison between
untreated Wistar and GK rats. b Comparison between untreated and treated Wistar rats. c Comparison between untreated and treated GK
rats. d Comparison between treated Wistar and untreated GK rats. W, untreated Wistar rats; Ws, SO-treated Wistar rats; GK, untreated Goto
Kakizaki rats; GKs, SO-treated Goto Kakizaki rats. The values shown represent the means±SEM of n=6–9 animals in each group. *p<0.05,
vs. untreated Wistar. §p<0.05, vs. untreated GK
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Table 2 Islet fatty acids of non-diabetic and diabetic rats untreated and treated with soybean oil
Non-diabetic rats Diabetic rats
W Ws GK GKs
Saturated (%) 79.2±1.8 77.2±3.2 75.5±0.8 76.1±2.3
Polyunsaturated (%) 6.2±1.3 9.5±1.6 7.6±1.1 8.0±0.8
Monounsaturated (%) 14.6±1.3 13.3±2.5 17.0±1.3 15.9±2.4
Total unsaturated (%) 20.8±1.8 22.8±3.2 24.5±0.8 23.9±2.3
Unsaturated/saturated 0.27±0.03 0.31±0.05 0.33±0.01 0.32±0.04
Unsaturated index 27.7±2.7 33.5±4.4 33.0±1.5 32.4±2.6
W, untreated Wistar rats; Ws, SO-treated Wistar rats; GK, untreated Goto-Kakizaki rats; GKs, SO-treated Goto-Kakizaki rats. The values
shown represent the means±SEM of n=6–9 animals in each group
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drome at this age. The cycle Randle hypothesis, also
known as the glucose–fatty acid cycle, postulates that the
increase of fatty acid oxidation causes a commensurate
decrease in glucose oxidation, leading to a decrease in
glucose uptake and hyperglycaemia [6]. We also observed
that in GK rats GSIS is drastically inhibited when isolat-
ed islets were exposed to 2, 8 and 11 mM of glucose (Fig.
2a), which is in accordance with previous studies from our
laboratory [40].
Analysing the fatty acid composition of untreated dia-
betic islets, we observed a significant decrease in saturat-
ed myristic acid (C14:0), an increase in monounsaturated
palmitoleic acid (C16:1) and the presence of the monoun-
saturated erucic acid (C22:1) (Fig. 3a) when compared
with untreated normal animals. It has been reported that
impaired GSIS observed in GK rats is associated with
alterations in β-cell glucose metabolism, protein kinase C
pathway, modulation of UCP-2 expression, acetylcholine
and oxidative stress [11, 26, 47–49]. However, it can also
be associated with fatty acid content alterations. Fatty
acids are key components of cellular membrane phospho-
lipids and are involved in intracellular mechanisms, as
previously described [12, 13]. Previous studies reported
the stimulatory effect of the monounsaturated palmitoleic
acid (C16:1) on KATP channel activity [16] and promotion
of β-cell function and proliferation at low glucose con-
centrations [27]. Although we observed a significant
increase in palmitoleic acid (C16:1) in untreated diabetic
islets (Fig. 3a), this increase is not sufficient to recover the
secretory capacity of islets. However, this may represent
an attempt of diabetic islets to recover their function. This
idea is also supported by the appearance of the C22:1 fatty
acid in untreated GK rats. The decrease in insulin secre-
tion in the presence of long-chain fatty acids, like C22:1
fatty acid, is in agreement with previous studies [7, 16].
SO is one of the most highly consumed oils world-
wide. In humans, increased fat consumption is closely
related to type 2 diabetes mellitus. Thus, our major goal
was to investigate the effects of SO sub-chronic (7 days)
treatment on insulin response of glucose-stimulated islets
isolated from diabetic GK and normal W rats as well as its
effect on islet fatty acid composition. In normal rats treat-
ed with SO, the increase in fasting plasma insulin and
maintenance of fasting glucose levels results in a signifi-
cant increase of HOMA and significant decrease of
QUICKIs (Fig. 1), indicating an increase in insulin resist-
ance. Shang and colleagues [38] demonstrated that Wistar
rats fed with a high-fat diet for 2 months did not present
alterations in glucose tolerance although enhanced insulin
secretion during oral glucose tolerance test was observed.
Wistar rats did not change body weight and plasma FFAs
levels under SO treatment (Table 1), indicating a normal
FFA uptake [50]. We also observed that GSIS from pan-
creatic islets isolated from treated Wistar rats was drasti-
cally inhibited. The impairment of insulin response was
observed at all concentrations of glucose and arginine
tested (Fig. 2b). Although GSIS decreased with SO treat-
ment, plasma FFA levels did not increase. Therefore, we
excluded the glucose–fatty acid cycle hypothesis, which
implies the increase of plasma FFAs and the impairment
of β-cell responsiveness to glucose [5]. Tinahones and
colleagues [12] suggested that secretion failure could be
related to alterations of islet fatty acids. Concerning this
issue we observed that treated Wistar rats present a signif-
icant decrease in two saturated fatty acids, myristic
(C14:0) and heneicosanoic (C21:0) acids, and one MUFA,
eicosenoic acid (C20:1), and the appearance of the
monounsaturated erucic acid (C22:1) (Fig. 3b). The
appearance of the long-chain C22:1 fatty acid and the
impairment of insulin secretion were consistent with pre-
vious studies reporting that the increase of the number of
carbons has a negative effect on insulin release by increas-
ing β-cell KATP channel activity and inducing the uncou-
pling of β-cell oxidative phosphorylation [7, 16]. Other
studies show that saturated fatty acids are associated with
a higher risk of type 2 diabetes [18, 20, 24]. In our study,
the decrease in saturated fatty acids observed in islets iso-
lated from treated W rats may represent an attempt of ani-
mals to circumvent the β-cell secretory deficiency.
Furthermore, our results indicate that islet fatty acid alter-
ations are positively associated with GSIS impairment
(Figs. 2b and 3b).
In summary, we observed that in normal Wistar rats,
SO treatment induces insulin resistance and islet insulin
secretion failure, which is in accordance with previous
studies [2, 20, 34, 35]. Furthermore, the impairment of
GSIS observed (Fig. 2b) could be the result of islet fatty
acid alterations. This suggestion is supported by previous
studies stating that besides the involvement of FFAs in
membrane phospholipids, they also act as lipid-signalling
molecules [12, 14, 17].
SO treatment in GK rats significantly decreased fasting
glucose levels but did not induce significant alterations in
HOMA, QUICKIs and glucose intolerance (Fig. 1).
Previous studies showed similar results in a type 2 diabet-
ic rat model. Those studies reported that three months of
SO diet did not induce a statistical change in body weight,
glucose tolerance or insulin resistance [33, 34]. However,
we also observed that SO treatment significantly increased
non-fasting plasma FFAs up to fasting levels. The impair-
ment of GSIS observed in GK rats is exacerbated by SO
treatment (Fig. 2c). Similar to SO-treated normal rats, the
decrease in insulin secretion occurred at all concentrations
of glucose and arginine tested. The regulation of insulin
secretion in vivo involves the interaction of several factors
besides glucose levels. Others nutrients as well as neural
and hormonal influences are responsible for insulin stimu-
lation in vivo. Furthermore, the glucagon/insulin ratio is
particularly related to fasting glucose levels. Altogether,
these can explain the discrepancy between the reduction of
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fasting blood glucose and the impairment of islet insulin
secretion. The increase of plasma FFA levels may be
directly involved in inhibition of GSIS, as supported by
the glucose–fatty acid cycle or by changes in UCP-2 lev-
els [6, 11]. Previous studies demonstrated that 48-h expo-
sure of pancreatic β-cells to high glucose and FFA levels
results in a 49% desensitisation and suppression of insulin
secretion [5, 6, 13]. We observed that SO treatment only
induces a significant decrease of palmitoleic acid (C16:1)
(Fig. 3c). Previous studies reported that the increase of the
monounsaturated palmitoleic acid (C16:1) is associated
with β-cell proliferation at low glucose concentrations
[27] and β-cell function improvement [12, 17].
Accordingly, the failure of SO-treated GK islet insulin
response observed in our study could be related to a
decrease in islet palmitoleic acid.
In summary, in treated GK rats, the increase in non-
fasting FFA levels and the potentiation of GSIS decrease
could be related to the interference of SO on the Randle
cycle or UCP-2 expression [6, 11, 13], as previously dis-
cussed. Furthermore, our results show that the exacerba-
tion of GSIS impairment could also be associated with the
decrease in palmitoleic acid (C16:1) levels.
In both groups of rats, SO treatment interferes with
islet fatty acid composition, this effect being independent
of SO fatty acid content. As shown in Table 3, islet fatty
acids that were significantly altered with SO treatment
correspond to fatty acids that are absent or present at
lower percentage in SO. It should be noted that the posi-
tive correlation between GSIS impairment (Fig. 2d) and
the levels of the erucic acid (C22:1, Fig. 3d) observed in
SO-treated W rats is similar to that found in untreated GK
rats, suggesting an association between C22:1 fatty acid
levels and insulin secretion. Furthermore, we observed a
similarity in fasting plasma insulin levels between SO-
treated normal and untreated diabetic rats (Fig. 1b).
Moreover, the insulin sensitivity index values of treated
normal rats approach those of untreated diabetic animals
(Fig. 1c, d).
Furthermore our results show that both groups of treat-
ed animals present different responses to SO treatment. In
normal Wistar rats, the treatment induces insulin resist-
ance and decreases GSIS similar to diabetic GK rats. This
could be justified by the changes of fatty acid composition
of islets of Langerhans (myristic, eicosanoic, hene-
icosanoic, erucic acids) that could interfere with cell
channels and receptor activities or lipid-signalling mole-
cules. In diabetic islet secretion, treatment interference
appears to be related with palmitoleic acid decrease and
the involvement of the Randle cycle or changes in UCP-2
levels. More studies should be performed to clarify the
exact role of different fatty acids on β-cell function.
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